Our mission
to reduce the burden of cardiovascular disease
Welcome! To enjoy a personalised experience, sign in.
Sign inWhat's Hot!
From science to events, it’s all right here
European Heart Journal - Valvular and Structural Heart Disease
Multimodality Assessment of Right Ventricular Function in Tricuspid Regurgitation and Its Impact on Outcomes in Patients undergoing Transcatheter Tricuspid Valve Interventions.
ESC Congress 2026 – register by 31 May to save the most
In Munich we will champion responsible progress, while celebrating the human connection that drives discovery. This is the place where transformation becomes collective. Because amid algorithms and automation, cardiology’s heartbeat remains human and progress begins with people. It begins with YOU.
New positive data on old drugs: Digitalis reduces heart failure events
Analyses supporting the use of digitalis glycosides in patients with heart failure were presented in a Late-Breaking Science session today at Heart Failure 2026.
ESC TV Today: Biomarkers in Heart Failure
As biomarkers take on a growing role in heart failure care, how can they improve diagnosis, guide treatment, and identify patients at risk of disease progression? What is the evolving role of NT-proBNP alongside imaging, implantable devices, and emerging biomarkers? Lynne Warner Stevenson discusses the future of personalised heart failure care.
FOCUS on Cardiovascular Disease in Women
This month, we bring you great resources on the right ventricle (RV) with practical approaches in clinical management and resources to helo you assess patients with RV.
EU pharmaceutical reform shows the value of sustained advocacy
The Council and the European Parliament’s Public Health Committee have backed a revised EU medicines framework, marking the first major update in over 20 years. This milestone follows years of negotiation and engagement with stakeholders, including the ESC.
Findings from the first randomised trial assessing RNA therapy in heart failure
Results from the first randomised trial evaluating microRNA inhibition in heart failure were presented today at Heart Failure 2026.
EHJ Dialogues
Join us on 28 May at 17:00 for an EHJ Dialogue with Prof. Andreas Zeiher. In this epidode he reflects on how our understanding of ischaemic heart disease has evolved over recent decades, sharing insights from his own contributions to advancing the field.
Bringing cardiologists’ voice to Europe through advocacy – every day
European health policy is moving fast, from cardiovascular health plans to medicines reform. Beyond the headlines, the ESC continues its long term advocacy efforts, building trusted relationships with EU institutions to deliver lasting benefits for cardiovascular health.
In Memoriam - Professor Eugene Braunwald
We are deeply saddened to learn of the passing of Prof. Eugene Braunwald, one of the most influential figures in the history of cardiovascular medicine. “Prof. Braunwald was the leading cardiologist of his time. His vision and innovation changed the trajectory of cardiovascular medicine". ESC President, Thomas F. Lüscher.
AcuteCVDays 2026
From 4 May to 7 June, enjoy free and unlimited access to a selection of educational resources related to cardiogenic shock in all its different facets. In partnership with the EACVI, EHRA, EAPCI and HFA.
Stay up to date
Great science, direct to your inbox!
Sign up for free to the My ESC News.
Congresses
Our congresses bring us together
To share knowledge, present the latest science, and shape the future of cardiovascular care.
Your Journal Selection
Explore this week's articles from the ESC Journal Family
Image of the week
Test your knowledge each week with our quick quiz and sharpen your diagnostic skills!
This week's image was submitted by Mohammad Nasser Khattab from Al Bassel Heart Institute, Damascus, Syria.
Current episode
Expert insights
- Heart Failure 2026: congress highlights with Theresa McDonagh
- The role of biomarkers in heart failure with Lynne Warner Stevenson
- New data on digoxin in HFrEF with Dirk van Veldhuisen
- Cardiology this Week: must-see recent trials
About the ESC
Driven by science, united for patients
We are a volunteer-led, not-for-profit medical society. Our members and decision-makers are scientists, clinicians, nurses and allied professionals working in all fields of cardiology.
We unite national cardiac societies from around the world. This unique network allows us to understand the impact of cardiovascular disease and how we can better reduce its burden. Our diversity is our strength.
Join our community
Whether you’re a student, early-career professional, or experienced cardiologist, there’s a place for you here.
From access to congress resources and webinars, to mentoring, and specialised training, you’ll be supported with tools to expand your knowledge.
Choose the membership that's right for you.
Explore our key offerings
ESC Clinical Practice Guidelines help you weigh up the benefits and risks in your decision making
2025 ESC Guidelines for the management of myocarditis and pericarditis
These guidelines introduce a comprehensive, patient-oriented framework for the diagnosis and management of IMPS, spanning the full disease spectrum.
2025 ESC Guidelines for the management of cardiovascular disease and pregnancy
The current Guidelines for the management of cardiovascular disease and pregnancy support health care professionals to manage and care for women with cardiovascular diseases before, during and after pregnancy.
2025 ESC/EACTS Guidelines for the management of valvular heart disease
The 2025 ESC/EACTS Guidelines update the 2021 valvular heart disease recommendations. Key revisions highlight the central role of the Heart Team, the importance of Heart Valve Centres, and advances in diagnostic imaging with clearer criteria for complex VHD. They also refine indications and timing for interventional options across the spectrum of VHD.
2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias
This 2025 Focused Update addresses changes in recommendations for the treatment of dyslipidaemias based on new evidence published since the 2019 version, up until 31 March 2025.
2025 ESC Clinical Consensus Statement on mental health and cardiovascular disease
This clinical consensus statement on mental health and cardiovascular disease highlights the multidirectional relationship between mental health, cardiovascular health and cardiovascular disease and its impact on cardiovascular risk and prognosis.
ESC Education
Your go-to destination for flexible courses
We know you're busy, so we've made it simple to develop your knowledge across three levels: Core Cardiology, Subspecialty and Expert.
Core Cardiology
Understanding and application of ESC Guidelines and preparation for the European Exam in Core Cardiology.
Specialty
Training, certification and clinical practice in cardiology subspecialties.
Experts
Continuous professional development for general cardiologists and established specialists.